CINV / Crucial Innovations Corp. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-229638 CRUCIAL INNOVATIONS CORP

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-229638 CRUCIAL INNOVATIONS COR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2024 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-229638 CRUCIAL INNOVATIONS CORP. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-229638 CRUCIAL INNOVATIONS

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2025 CRUCIAL INNOVATIONS CORP. (Exact Name of Registrant as Specified in its Charter) Nevada 333-229638 98-1446012 (State or Other Jurisdiction (Commission File (IRS Employer

16.1 Letter from RBSM LLP dated May 23, 2025.

New York Office: 805 Third Avenue New York, NY 10022 212.838.5100 www.rbsmllp.com Exhibit 16.1 May 23, 2025 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read Item 4.01 of Form 8-K dated May 22, 2025 of CRUCIAL INNOVATIONS CORP. and are in agreement with the statements contained therein as it regards our firm. We have no basis to agree or

Share Purchase Agreement, dated May 8, 2023, including amendment, between the Company and certain sellers, concerning the acquisition of WLR Farming (Pty) Ltd.*

EXHIBIT 10(B)

Amended and Restated Bylaws of the Company.*

EXHIBIT 3(b) BYLAWS OF CRUCIAL INNOVATIONS CORP. (Adopted Effective February , 2024) TABLE OF CONTENTS Page Article I CORPORATE OFFICES 1 1.1 REGISTERED OFFICE. 1 1.2 OTHER OFFICES. 1 Article II MEETINGS OF STOCKHOLDERS 1 2.1 PLACE OF MEETINGS. 1 2.2 ANNUAL MEETING. 1 2.3 SPECIAL MEETING. 5 2.4 NOTICE OF STOCKHOLDER’S MEETINGS; AFFIDAVIT OF NOTICE. 5 2.5 QUORUM. 6 2.6 Organization. 6 2.7 CONDUCT O

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-229638 CRUCIAL INNOVATIONS CORP

Amended and Restated Articles of Incorporation of the Company.*

Exhibit 3(a) RESTATED ARTICLES OF INCORPORATION Crucial Innovations Corp., a corporation organized and existing under the laws of the State of Nevada, hereby certifies as follows: 1. The corporation was formed on February 28, 2018 when the original Articles of Incorporation of the corporation were filed with the Secretary of State of Nevada. 2. Pursuant to Chapter 78, Title 7 of Nevada Revised Sta

Share Purchase Agreement, dated May 8, 2023, including amendment, between the Company and certain sellers, concerning the acquisition of WLR Farming (Pty) Ltd.*

EXHIBIT 10(B)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-229638 CRUCIAL INNOVATIONS COR

2024 Equity Incentive Plan*

EXHIBIT 10(B) CRUCIAL INNOVATIONS CORP. 2024 EQUITY INCENTIVE PLAN 1. PURPOSE. The purpose of this Plan is to provide incentives to attract, retain and motivate eligible persons whose present and potential contributions are important to the success of the Company, and any Subsidiaries that exist now or in the future, by offering them an opportunity to participate in the Company’s future performanc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-229638 CRUCIAL INNOVATIONS CORP. (

Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2024 CRUCIAL INNOVATIONS CORP. (Exact Name of Registrant as Specified in its Charter) Nevada 333-229638 98-1446012 (State or Other Jurisdiction (Commission File (IRS Employer O

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-229638 CRUCIAL INNOVATIONS CORP. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-229638 CRUCIAL INNOVATIONS

OMB APPROVAL

NT 10-Q 1 crucnt10q.htm NT 10-Q OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response 2.50 FORM 12b-25 SEC FILE NUMBER 333-229638 NOTIFICATION OF LATE FILING CUSIP NUMBER 228771 101 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CS

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO S

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-229638 CRUCIAL INNOVATIONS CORP. (

OMB APPROVAL

OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response 2.50 FORM 12b-25 SEC FILE NUMBER 333-229638 NOTIFICATION OF LATE FILING CUSIP NUMBER 228771 101 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: June 30, 202

Lease Agreement by and between Sustain Resources (Private) Limited and Eco-Equity Zimbabwe (Private) Limited dated September 1, 2019.

EXHIBIT 10.3

Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) of the SECURITIES EXCHANGE ACT OF 1934 July 13, 2022 Date of Report (Date of Earliest event reported) CRUCIAL INNOVATIONS CORP. (Exact Name of Registrant as Specified in Charter) Nevada 333-229638 98-1446012 (State or other Jurisdiction of incorporation) (Commission File

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-229638 CRUCIAL INNOVATIONS CORP.

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Mark One ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTI

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Mark One ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-229638 CRUCIAL INNOVATIONS CORP. (Exac

Form of Share Exchange Agreement dated April 13, 2022, by and between Crucial Innovations Corp. and the Stockholders of Eco Equity Limited.

EXHIBIT 10.1 SHARE EXCHANGE AGREEMENT THIS SHARE EXCHANGE AGREEMENT (the “Agreement”) is dated as of April 13, 2022 (the “Effective Date”), is made by and between Crucial Innovations Corp., a Nevada corporation (“CINV”), on the one hand, and the several individuals that have executed a counterpart signature page (each a “Stockholder,” and collectively, the “Stockholders”), each of which owns share

Registry of shares of Eco-Equity Zimbabwe (Private) Limited.

EX-10.2 3 crucex102.htm REGISTRY OF SHARES EXHIBIT 10.2

OMB APPROVAL

OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response 2.50 FORM 12b-25 SEC FILE NUMBER 333-229638 NOTIFICATION OF LATE FILING CUSIP NUMBER 228771 101 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: March 31, 20

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

NT 10-K 1 crucnt10k.htm NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: March 31, 2022 Estimated average burden hours per response .........2.50 SEC FILE NUMBER 333-229638 CUSIP NUMBER 228771 101 (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-229638 CRUCIAL INNOVATIONS CO

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) of the SECURITIES EXCHANGE ACT OF 1934 October 17, 2021 Date of Report (Date of Earliest event reported) Crucial Innovations Corp. (Exact Name of Registrant as Specified in Charter) Nevada 333-229638 98-1446012 (State or other Jurisdiction of incorporation) (Commission Fi

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO S

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-229638 CRUCIAL INNOVATIONS CORP. (

Share Purchaser Agreement dated September 13, 2021 by and between Crucial Innovations Corp. and JPD Capital PPC.

EXHIBIT 2.01 SHARE PURCHASE AGREEMENT THIS SHARE PURCHASE AGREEMENT (the ?Agreement?) is dated September 13, 2021, and is made and agreed by and between CRUCIAL INNOVATIONS CORP., a Nevada corporation publicly traded on OTC Markets with trading Symbol ?CINV? as Buyer, (?Buyer? or ?CINV?) and JPD Capital PCC ( Company Number 66812 ), a Guernsey Channel Island company, having a business address o f

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) of the SECURITIES EXCHANGE ACT OF 1934 September 13, 2021 Date of Report (Date of Earliest event reported) Crucial Innovations Corp. (Exact Name of Registrant as Specified in Charter) Nevada 333-229638 98-1446012 (State or other Jurisdiction of incorporation) (Commission

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) of the SECURITIES EXCHANGE ACT OF 1934 September 2, 2021 Date of Report (Date of Earliest event reported) Crucial Innovations Corp. (Exact Name of Registrant as Specified in Charter) Nevada 333-229638 98-1446012 (State or other Jurisdiction of incorporation) (Commission F

Mutual Termination Agreement dated September 2, 2021 by and between Crucial Innovations Corp. and Mercantile Global Holdings, Inc.

EXHIBIT 10.1 MUTUAL TERMINATION AGREEMENT This Mutual Termination Agreement (the ?Termination Agreement?) is made and entered into this September 2, 2021 is between CRUCIAL INNOVATIONS CORP., a Nevada Corporation (?CINV?) and MERCANTILE GLOBAL HOLDINGS, INC., a Delaware Corporation (?MGH?). CINV and MGH may be referred individually as a ?Party? and collectively as the ?Parties?. RECITALS WHEREAS,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0058 Expires: February 28, 2022 Estimated average burden hours per response............. 2.50 FORM 12b-25 SEC FILE NUMBER 333-229638 NOTIFICATION OF LATE FILLING CUSIP NUMBER 228771 101 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10- Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period E

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ☐ TRANSITION REPORT PURSUANT TO

10-Q 1 cruc10q.htm FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-2296

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K Mark One ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTI

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K Mark One ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-229638 CRUCIAL INNOVATIONS, CORP. (Exa

UNITED STATES

UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0058 Expires: February 28, 2022 Estimated average burden hours per response............. 2.50 FORM 12b-25 SEC FILE NUMBER 333-229638 CUSIP NUMBER 228771 101 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form N-CSR ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN For Period End

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ________)*

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* CRUCIAL INNOVATIONS CORP. (Name of Issuer) Common Stock, $0.0001 Par Value (Title of Class of Securities) 0001766016 (CUSIP Number) Paul Machel First Choice Marketing Group LLC 2630 W. Broward Blvd., Suite 203-581 Fort Lauderdale, FL 33312 (619) 572-2348

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ________)*

SC 13D 1 crucsc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* CRUCIAL INNOVATIONS CORP. (Name of Issuer) Common Stock, $0.0001 Par Value (Title of Class of Securities) 0001766016 (CUSIP Number) Miroslaw Gorny The Consulting Agency LLC 2630 W. Broward Blvd., Suite 203-581 Fort Lauderdale

- NT 10-K

NT 10-K 1 crucnt10k.htm NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: February 28, 2022 Estimated average burden hours per response............ 2.50 SEC FILE NUMBER 333-229638 CUSIP NUMBER 228771 101 (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-

Equity Purchase Agreement dated December 31, 2020, by and between Crucial Innovations Corp. and Mercantile Global Holdings, Inc.

EXHIBIT 2.1 Execution Copy EQUITY PURCHASE AGREEMENT Between CRUCIAL INNOVATIONS CORP. AND MERCANTILE GLOBAL HOLDINGS, INC. THIS EQUITY PURCHASE AGREEMENT (the “Agreement”) dated December 31, 2020, is between CRUCIAL INNOVATIONS CORP., a Nevada corporation (“Buyer” or “CINV”) and MERCANTILE GLOBAL HOLDINGS INC, a Delaware Corporation (“Seller” or “MGH”). Buyer and Seller are referred to individual

Entry into a Material Definitive Agreement

8-K 1 cruc8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) of the SECURITIES EXCHANGE ACT OF 1934 December 31, 2020 Date of Report (Date of Earliest event reported) Crucial Innovations Corp. (Exact Name of Registrant as Specified in Charter) Nevada 333-229638 98-1446012 (State or other Jurisdiction of in

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Unregistered Sales of Equity Securities - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) of the SECURITIES EXCHANGE ACT OF 1934 November 9, 2020 Date of Report (Date of Earliest event reported) Crucial Innovations Corp. (Exact Name of Registrant as Specified in Charter) Nevada 333-229638 98-1446012 (State or other Jurisdiction of incorporation) (Commission Fi

Quarterly Report -

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Mark One [ X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-229638 CRUCIAL INNOVATIO

Quarterly Report -

10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Mark One [ X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-229638 CRUCIAL INNOVATIO

CINV / CRUCIAL INNOVATIONS CORP 10-Q - Quarterly Report - 10-Q

10-Q 1 crucial10qmarch3120202.htm 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Mark One [ X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission Fi

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K Mark One [ X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-229638 CRUCIAL INNOVATIONS, CO

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K Mark One [ X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-229638 CRUCIAL INNOVATIONS, CO

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Mark One [ X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-229638 CRUCIAL INNOVATIO

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Mark One [ X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-229638 CRUCIAL INNOVATIO

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Mark One [ X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-229638 CRUCIAL INNOVATIONS,

CRUCIAL INNOVATIONS, CORP.

CRUCIAL INNOVATIONS, CORP. April 04, 2019 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Attention: Gregory Dundas and Kathleen Krebs Division of Corporation Finance Office of Telecommunications Re: Crucial Innovations, Corp. Registration Statement on Form S-1 File No. 333-229638 REQUEST FOR ACCELERATION OF EFFECTIVENESS Pursuant to Rule 461 prom

CRUCIAL INOVATIONS, CORP.

CRUCIAL INOVATIONS, CORP. Xibahe Beili 25, Beijing, China 100096 April 1, 2019 Gregory Dundas and Kathleen Krebs Division of Corporation Finance Office of Telecommunications U.S. Securities and Exchange Commission 100 F Street, NE, Washington, DC 20549 Reference: Crucial Innovations, Corp. Registration Statement on Form S-1 Filed March 21, 2019 File No. 333-229638 Gregory Dundas and Kathleen Krebs

As Filed with the Securities and Exchange Commission on April 1 , 2019

As Filed with the Securities and Exchange Commission on April 1 , 2019 Registration No.

CRUCIAL INOVATIONS, CORP. Xibahe Beili 25, Beijing, China 100096

CRUCIAL INOVATIONS, CORP. Xibahe Beili 25, Beijing, China 100096 March 21, 2019 Gregory Dundas and Kathleen Krebs Division of Corporation Finance Office of Telecommunications U.S. Securities and Exchange Commission 100 F Street, NE, Washington, DC 20549 Reference: Crucial Innovations, Corp. Registration Statement on Form S-1 Filed February 13, 2019 File No. 333-229638 Gregory Dundas and Kathleen K

As Filed with the Securities and Exchange Commission on March 21 , 2019

As Filed with the Securities and Exchange Commission on March 21 , 2019 Registration No.

As Filed with the Securities and Exchange Commission on February 13, 2019

As Filed with the Securities and Exchange Commission on February 13, 2019 Registration No.

WEBSITE PURCHASE AGREEMENT

EX-10.2 6 ex10-2.htm Exhibit 10.2 WEBSITE PURCHASE AGREEMENT This Website Purchase Agreement (the "Agreement ") is made effective on November 29,2018(the "Effective Date"), by and between Vitalii Ovechko, of 4 Koscielna Street, Garwolin, 08-400 (the "Seller"), and CRUCIAL INNOVATIONS, CORP., of Xibahe Beili 25, Beijing, China 100096 (the "Buyer "). PURCHASE The Seller hereby sells and transfers to

Articles of Incorporation filed with the Nevada Secretary of State of February 28, 2018.

Exhibit 3.1 BARBARA K. CEGAVSKE Secretary of State 202 North Carson Street Carson City, Nevada 89701-4201 (775) 684-5708 Website: www. nvsos.gov Filed in the office of /s/ Barbara K. Cegavske Barbara K. Cegavske Secretary of State State of Nevada Document Number 20180094033-50 Filing Date and Time 02/28/2018 12:27 PM Entity Number E0102982018-3 Articles of Incorporation (Pursuant to NRS CHAPTER78)

STOCK SUBSCRIPTION AGREEMENT

EX-99 9 ex99-1.htm Exhibit 99.1 STOCK SUBSCRIPTION AGREEMENT TO: CRUCIAL INNOVATIONS, CORP. Dear Sirs: Concurrent with the execution of this Subscription Agreement, the undersigned (the “Purchaser”) is purchasing Shares of Common Stock of Crucial Innovations, Corp. (the “Company”), pursuant to an offering being made to non-U.S. residents only. Purchaser hereby confirms the subscription for and pur

3 (ii)

Exhibit 3.2 BYLAWS of CRUCIAL INNOVATIONS, CORP. (the "Corporation") ARTICLE I: MEETINGS OF SHAREHOLDERS Section 1 - Annual Meetings The annual meeting of the shareholders of the Corporation shall be held at the time fixed, from time to time, by the Board of Directors. Section 2 - Special Meetings Special meetings of the shareholders may be called by the Board of Directors or such person or person

Crucial Innovations,Corp. Xibahe Beili 25 Beijing, China 100096

Exhibit 10.3 Crucial Innovations,Corp. Xibahe Beili 25 Beijing, China 100096 June 01, 2018 Reinis Kosins Xibahe Beili 25, Beijing, China 100096 Consulting Agreement This agreement between Reinis Kosins (Consultant) and Crucial Innovations, Corp. (Company). Whereby Consultant will provide services which include managing the overall operations of the Company required by Crucial Innovations, Corp. fo

FUTURE LOAN(S) AGREEMENT

EX-10.1 5 ex10-1.htm Exhibit 10.1 FUTURE LOAN(S) AGREEMENT THE PARTIES TO THIS AGREEMENT ARE: The Lender: Reinis Kosins The Company: CRUCIAL INNOVATIONS, Corp. Whereas the Lender agrees to lend funds to the Company when needed to help pay for its business expenses as outlined in its “Plan of Operations” in the SEC Form S-1 filing. The Parties agree to the following: 1. The duration of this agreeme